ConvaTec Group PLC (LSE:CTEC) - Share price

Stock Report

ConvaTec Group PLC CTEC

Last Price

Day Change

As of 03/04/2020
17:47:21 BST | GBX
Minimum 15 Minutes Delay.

Last Close180.70p
Day Range178.40 - 187.60
Mkt Cap3.57Bil
52-Wk Range130.60 - 225.80
Yield %2.50

Share Price

Total Returns 03/04/2020

 Chg (%)  
More ...
ConvaTec Group PLC-4.86 
FTSE 100 TR GBP-19.26
More ...
Income Statement
Operating Profit247.80267.70202.40
Net Profit158.10221.609.80
Reported EPS0.080.110.01
Balance Sheet
Current Assets875.10903.20968.30
Non Current Assets2,925.802,757.202,641.50
Total Assets3,800.903,660.403,609.80
Current Liabilities338.50330.90397.30
Total Liabilities---
Total Equity1,523.801,617.201,561.00
Cash Flow
Operating Cash Flow353.50387.80438.80
Net Change in Cash4.7041.7076.50

Regulatory News

DateAuthor Headline
08/11/2018Alex Morozov, CFA Vodafone Added to Value Stocks List
UK accountancy tech firm Sage was booted off the Morningstar Europe Core Pick List of the most attractively valued stocks, but Vodafone was added
03/08/2018Alex Morozov, CFA 7 UK Stocks Make the European Value Picks List
The Morningstar Europe Core Pick List features the most attractively valued stocks that possess sustainable competitive advantages
19/12/2017David Brenchley Best Performing FTSE 100 Stocks of 2017
While the FTSE 100 has lagged most major indices this year, almost 70% of its constituents have seen their share price rise
Director Dealings
More ...
12/03/2020PurchaseMr. Brian Michael May160.3625,00040,091.00
12/03/2020PurchaseMs. Margaret Ewing160.8310,00016,083.00
10/03/2020PurchaseDr. John David Gibson McAdam171.0923,18139,660.00
08/01/2020PurchaseDr. Regina M. Benjamin209.3410,00020,934.00

Company Profile

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.


Medical Instruments & Supplies


FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 07/05/2020

Annual General Meeting
More ...
PER (E)465.22
Div Yld (E)2.41
PEG (E)0.00
Op Mrgn0.11
EPS Grwth-0.56
More ...
Record Date06/09/1903/04/20
More ...
Non-Executive DirectorRick D. Anderson
Non-Executive DirectorProfessor Sten Scheibye, PhD
Non-Executive Director, ChairmanDr. John David Gibson McAdam
Non-Executive DirectorMr. Brian Michael May
Non-Executive Director, Senior Independent DirectorMs. Margaret Ewing
Executive Director, Chief Executive OfficerKarim Bitar
Non-Executive DirectorDr. Rosalind Catherine Rivaz
Non-Executive DirectorDr. Regina M. Benjamin
Executive Director, Chief Financial OfficerFrank Schulkes
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.